- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
The role of CD180 in hematological malignancies and inflammatory disorders ; volume:29 ; number:1 ; day:17 ; month:7 ; year:2023 ; pages:1-22 ; date:12.2023
Molecular medicine ; 29, Heft 1 (17.7.2023), 1-22, 12.2023
- Creator
-
Edwards, Kurtis
Lydyard, Peter M.
Kulikova, Nino
Tsertsvadze, Tamar
Volpi, Emanuela V.
Chiorazzi, Nicholas
Porakishvili, Nino
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s10020-023-00682-x
- URN
-
urn:nbn:de:101:1-2023102409102301059634
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Edwards, Kurtis
- Lydyard, Peter M.
- Kulikova, Nino
- Tsertsvadze, Tamar
- Volpi, Emanuela V.
- Chiorazzi, Nicholas
- Porakishvili, Nino
- SpringerLink (Online service)
Other Objects (12)
Role of CD47 in Hematological Malignancies
Deubiquitinases in hematological malignancies
Checkpoint inhibitors in hematological malignancies
Rac GTPases in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Targeting immune checkpoints in hematological malignancies
Cellular immunotherapy for refractory hematological malignancies
IL-31, itch and hematological malignancies
Targeting splicing for hematological malignancies therapy
The role of proteostasis in hematological malignancies and the therapeutic implications
Targeting posttranslational modifications to treat hematological malignancies
Role of CD47 in Hematological Malignancies
Deubiquitinases in hematological malignancies
Checkpoint inhibitors in hematological malignancies
Rac GTPases in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Targeting immune checkpoints in hematological malignancies
Cellular immunotherapy for refractory hematological malignancies
IL-31, itch and hematological malignancies
Targeting splicing for hematological malignancies therapy
The role of proteostasis in hematological malignancies and the therapeutic implications
Targeting posttranslational modifications to treat hematological malignancies
Role of CD47 in Hematological Malignancies
Deubiquitinases in hematological malignancies
Checkpoint inhibitors in hematological malignancies
Rac GTPases in hematological malignancies
Hematological Malignancies and Arterial Thromboembolism
Mitochondrial transfer in hematological malignancies
Targeting immune checkpoints in hematological malignancies
Cellular immunotherapy for refractory hematological malignancies
IL-31, itch and hematological malignancies
Targeting splicing for hematological malignancies therapy
The role of proteostasis in hematological malignancies and the therapeutic implications